Back to Search
Start Over
The evolution in management of patients with subcentimeter, node-negative, triple-negative breast cancer.
- Source :
-
American Journal of Surgery . 2013, Vol. 206 Issue 6, p888-893. 6p. - Publication Year :
- 2013
-
Abstract
- BACKGROUND: The aim of this study was to determine the evolution in treatment recommendations and outcomes for patients with subcentimeter, node-negative, triple-negative disease. METHODS: Patients were divided into a remote (diagnosed from 1997 to 2003) and a recent (diag-nosed from 2004 to 2011) group. Demographics, tumor size, surgical treatment, use of adjuvant che-motherapy, survival, and disease recurrence were evaluated. RESULTS: Thirty patients were placed in the remote group and 31 in the recent group. Demograph-ics, tumor sizes, and surgical treatment were similar between groups. The use of adjuvant chemother-apy increased from 7% to 42% in the recent group (P < .002). Disease-free survival and recurrence (7%) was not influenced by the use of chemotherapy. CONCLUSIONS: This study demonstrates that adjuvant chemotherapy is increasingly used in pa-tients with the triple-negative phenotype, regardless of other favorable prognostic variables. The value of adjuvant chemotherapy for the subgroup of patients in our study is unclear and mandates further investigation. [ABSTRACT FROM AUTHOR]
- Subjects :
- *DEMOGRAPHIC surveys
*TUMORS
*SURGERY
*CANCER chemotherapy
*PHENOTYPES
Subjects
Details
- Language :
- English
- ISSN :
- 00029610
- Volume :
- 206
- Issue :
- 6
- Database :
- Academic Search Index
- Journal :
- American Journal of Surgery
- Publication Type :
- Academic Journal
- Accession number :
- 92709980
- Full Text :
- https://doi.org/10.1016/j.amjsurg.2013.08.011